Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease

Research output: Contribution to journal › Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{c2cdbf718c9b442cb268e01a7a49c6a3,

title = "Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease",

author = "Michael Hughes",

year = "2022",

month = jul,

doi = "10.1016/s2665-9913(22)00183-7",

language = "English",

journal = "The Lancet Rheumatology",

issn = "2665-9913",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease

AU - Hughes, Michael

PY - 2022/7

Y1 - 2022/7

UR - http://dx.doi.org/10.1016/s2665-9913(22)00183-7

U2 - 10.1016/s2665-9913(22)00183-7

DO - 10.1016/s2665-9913(22)00183-7

M3 - Article

SN - 2665-9913

JO - The Lancet Rheumatology

JF - The Lancet Rheumatology

ER -